These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28160356)

  • 1. Ferumoxytol vs. Gadolinium agents for contrast-enhanced MRI: Thoughts on evolving indications, risks, and benefits.
    Finn JP; Nguyen KL; Hu P
    J Magn Reson Imaging; 2017 Sep; 46(3):919-923. PubMed ID: 28160356
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.
    Hamilton BE; Nesbit GM; Dosa E; Gahramanov S; Rooney B; Nesbit EG; Raines J; Neuwelt EA
    AJR Am J Roentgenol; 2011 Oct; 197(4):981-8. PubMed ID: 21940589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
    Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol.
    Daldrup-Link HE; Theruvath AJ; Rashidi A; Iv M; Majzner RG; Spunt SL; Goodman S; Moseley M
    Pediatr Radiol; 2022 Feb; 52(2):354-366. PubMed ID: 34046709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression.
    Barajas RF; Hamilton BE; Schwartz D; McConnell HL; Pettersson DR; Horvath A; Szidonya L; Varallyay CG; Firkins J; Jaboin JJ; Kubicky CD; Raslan AM; Dogan A; Cetas JS; Ciporen J; Han SJ; Ambady P; Muldoon LL; Woltjer R; Rooney WD; Neuwelt EA
    Neuro Oncol; 2019 Mar; 21(4):517-526. PubMed ID: 30277536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of ferumoxytol with gadolinium as contrast agents for the diagnostic magnetic resonance imaging of osteomyelitis.
    Langsjoen J; Neuwelt A; Eberhardt S; Mlady G; Shukla U; Murali S; Pizanis C; Sillerud LO
    Magn Reson Imaging; 2020 Sep; 71():45-54. PubMed ID: 32439428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferumoxytol negatively enhances T
    Neuwelt A; Langsjoen J; Byrd T; Eberhardt S; Mlady G; Baca J; Bocklage T; Martinez C; Orner J; Rivera M; Sillerud LO
    J Magn Reson Imaging; 2017 Apr; 45(4):1241-1245. PubMed ID: 27654009
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging applications for ferumoxytol as a contrast agent in MRI.
    Bashir MR; Bhatti L; Marin D; Nelson RC
    J Magn Reson Imaging; 2015 Apr; 41(4):884-98. PubMed ID: 24974785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.
    Mukundan S; Steigner ML; Hsiao LL; Malek SK; Tullius SG; Chin MS; Siedlecki AM
    Am J Kidney Dis; 2016 Jun; 67(6):984-8. PubMed ID: 26786296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferumoxytol-Enhanced MRI Is Not Inferior to Gadolinium-Enhanced MRI in Detecting Intracranial Metastatic Disease and Metastasis Size.
    Hamilton BE; Barajas R; Nesbit GM; Fu R; Ambady P; Taylor M; Neuwelt EA
    AJR Am J Roentgenol; 2020 Dec; 215(6):1436-1442. PubMed ID: 33052739
    [No Abstract]   [Full Text] [Related]  

  • 11. Dark Blood Magnetic Resonance Lymphangiography Using Dual-Agent Relaxivity Contrast (DARC-MRL): A Novel Method Combining Gadolinium and Iron Contrast Agents.
    Maki JH; Neligan PC; Briller N; Mitsumori LM; Wilson GJ
    Curr Probl Diagn Radiol; 2016; 45(3):174-9. PubMed ID: 26460054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Imaging With Ferumoxytol as a Contrast Agent.
    Hope MD; Hope TA; Zhu C; Faraji F; Haraldsson H; Ordovas KG; Saloner D
    AJR Am J Roentgenol; 2015 Sep; 205(3):W366-73. PubMed ID: 26102308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of ferumoxytol in children undergoing cardiac MRI under general anaesthesia.
    Wise-Faberowski L; Velasquez N; Chan F; Vasanawala S; McElhinney DB; Ramamoorthy C
    Cardiol Young; 2018 Jul; 28(7):916-921. PubMed ID: 29848399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
    Gahramanov S; Raslan AM; Muldoon LL; Hamilton BE; Rooney WD; Varallyay CG; Njus JM; Haluska M; Neuwelt EA
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):514-23. PubMed ID: 20395065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferumoxytol-Enhanced MRI in Children and Young Adults: State of the Art.
    Adams LC; Jayapal P; Ramasamy SK; Morakote W; Yeom K; Baratto L; Daldrup-Link HE
    AJR Am J Roentgenol; 2023 Apr; 220(4):590-603. PubMed ID: 36197052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative comparison of delayed ferumoxytol T
    Horváth A; Varallyay CG; Schwartz D; Toth GB; Netto JP; Barajas R; Várallyay P; Szidonya L; Firkins J; Youngers E; Fu R; Ambady P; Bogner P; Neuwelt EA
    Magn Reson Med; 2018 Jul; 80(1):224-230. PubMed ID: 29205477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular MRI with ferumoxytol.
    Finn JP; Nguyen KL; Han F; Zhou Z; Salusky I; Ayad I; Hu P
    Clin Radiol; 2016 Aug; 71(8):796-806. PubMed ID: 27221526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic physics of MR contrast agents and maximization of image contrast.
    Hendrick RE; Haacke EM
    J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular applications of ferumoxytol-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Bowman AW; Gooch CR; Alexander LF; Desai MA; Bolan CW
    Abdom Radiol (NY); 2021 May; 46(5):2203-2218. PubMed ID: 33090256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents.
    Siedek F; Muehe AM; Theruvath AJ; Avedian R; Pribnow A; Spunt SL; Liang T; Farrell C; Daldrup-Link HE
    Eur Radiol; 2020 Mar; 30(3):1790-1803. PubMed ID: 31844962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.